CONTEXT: The timing and frequency of GH secretory episodes is regulated by GHRH and somatostatin. This study provides evidence for amplification of these GH pulses by endogenous acyl-ghrelin. DESIGN: Blood was sampled every 10 min for 26.5 h during a fed admission with standardized meals and also during the final 24 h of a 61.5-h fast. GH secretion profiles were derived from deconvolution of 10-min sampling data, and full-length acyl-ghrelin levels were measured using a newly developed two-site sandwich assay. SETTING: The study was conducted at a university hospital general clinical research center. PARTICIPANTS: Participants included eight men with mean (+/- sd) age 24.5 +/- 3.7 yr (body mass index 24 +/- 2.1 kg/m(2)). RESULTS: Correlations were computed between amplitudes of individual GH secretory events and the average acyl-ghrelin concentration in the 60-min interval preceding each GH burst. In the fed state, the peak correlations were positive for all subjects and significantly higher than in the fasting state when acyl-ghrelin levels declined [mean (+/- sem): 0.7 (0.04) vs. 0.29 (0.08), P = 0.017]. In addition, long-term fasting was associated with an increase in the GH secretory pulse mass and amplitude but not frequency [fed vs. fasting pulse mass: 0.22 (0.05) vs. 0.44 (0.06) microg/liter, P = 0.002; amplitude: 5.2 (1.3) vs. 11.8 (1.9) microg/liter/min, P = 0.034; pulses per 24 h: 19.4 (0.5) vs. 22.0 (1.4), P = 0.1]. CONCLUSION: Our data support the hypothesis that under normal conditions in subjects given regular meals endogenous acyl-ghrelin acts to increase the amplitude of GH pulses.
CONTEXT: The timing and frequency of GH secretory episodes is regulated by GHRH and somatostatin. This study provides evidence for amplification of these GH pulses by endogenous acyl-ghrelin. DESIGN: Blood was sampled every 10 min for 26.5 h during a fed admission with standardized meals and also during the final 24 h of a 61.5-h fast. GH secretion profiles were derived from deconvolution of 10-min sampling data, and full-length acyl-ghrelin levels were measured using a newly developed two-site sandwich assay. SETTING: The study was conducted at a university hospital general clinical research center. PARTICIPANTS: Participants included eight men with mean (+/- sd) age 24.5 +/- 3.7 yr (body mass index 24 +/- 2.1 kg/m(2)). RESULTS: Correlations were computed between amplitudes of individual GH secretory events and the average acyl-ghrelin concentration in the 60-min interval preceding each GH burst. In the fed state, the peak correlations were positive for all subjects and significantly higher than in the fasting state when acyl-ghrelin levels declined [mean (+/- sem): 0.7 (0.04) vs. 0.29 (0.08), P = 0.017]. In addition, long-term fasting was associated with an increase in the GH secretory pulse mass and amplitude but not frequency [fed vs. fasting pulse mass: 0.22 (0.05) vs. 0.44 (0.06) microg/liter, P = 0.002; amplitude: 5.2 (1.3) vs. 11.8 (1.9) microg/liter/min, P = 0.034; pulses per 24 h: 19.4 (0.5) vs. 22.0 (1.4), P = 0.1]. CONCLUSION: Our data support the hypothesis that under normal conditions in subjects given regular meals endogenous acyl-ghrelin acts to increase the amplitude of GH pulses.
Authors: M A Bednarek; S D Feighner; S S Pong; K K McKee; D L Hreniuk; M V Silva; V A Warren; A D Howard; L H Van Der Ploeg; J V Heck Journal: J Med Chem Date: 2000-11-16 Impact factor: 7.446
Authors: E Arvat; M Maccario; L Di Vito; F Broglio; A Benso; C Gottero; M Papotti; G Muccioli; C Dieguez; F F Casanueva; R Deghenghi; F Camanni; E Ghigo Journal: J Clin Endocrinol Metab Date: 2001-03 Impact factor: 5.958
Authors: Hiralal G Maheshwari; Suzan S Pezzoli; Asad Rahim; Stephen M Shalet; Michael O Thorner; Gerhard Baumann Journal: Am J Physiol Endocrinol Metab Date: 2002-04 Impact factor: 4.310
Authors: E V Dimaraki; C A Jaffe; R Demott-Friberg; M Russell-Aulet; C Y Bowers; P Marbach; A L Barkan Journal: Am J Physiol Endocrinol Metab Date: 2001-03 Impact factor: 4.310
Authors: Alex F Muller; Steven W J Lamberts; Joop A M J L Janssen; Leo J Hofland; Peter Van Koetsveld; Martin Bidlingmaier; Christian J Strasburger; Ezio Ghigo; Aart Jan Van der Lely Journal: Eur J Endocrinol Date: 2002-02 Impact factor: 6.664
Authors: Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen Journal: Endocr Rev Date: 2012-03-20 Impact factor: 19.871
Authors: Robert Lin Li; Daniel P Sherbet; Benjamin L Elsbernd; Joseph L Goldstein; Michael S Brown; Tong-Jin Zhao Journal: J Biol Chem Date: 2012-04-03 Impact factor: 5.157
Authors: Ralf Nass; Leon S Farhy; Jianhua Liu; Suzan S Pezzoli; Michael L Johnson; Bruce D Gaylinn; Michael O Thorner Journal: J Clin Endocrinol Metab Date: 2013-11-27 Impact factor: 5.958
Authors: Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio Journal: J Clin Endocrinol Metab Date: 2013-04-15 Impact factor: 5.958
Authors: Ralf Nass; Jianhua Liu; James Patrie; Suzan S Pezzoli; Leon S Farhy; Bruce D Gaylinn; Michael O Thorner Journal: J Clin Endocrinol Metab Date: 2014-06-25 Impact factor: 5.958
Authors: Remberto C Paulo; Richard Brundage; Mihaela Cosma; Kristi L Mielke; Cyril Y Bowers; Johannes D Veldhuis Journal: J Clin Endocrinol Metab Date: 2008-08-12 Impact factor: 5.958